TrademarkOpen
Search / United States / 98112146

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

MODE

Allowed — statement of use stage
Fifth Extension - Granted
Used for: Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing…
Show more

Class 5: Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Class 42: Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS

Status timeline

  1. 4 Aug 2023
    Application filed
    New Application Entered
  2. 23 Sep 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 25 Sep 2023
    Approved for publication
    Approved For Pub - Principal Register
  4. 31 Oct 2023
    Published for opposition
    Published For Opposition
  5. 26 Dec 2023
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 5 Jan 2024
    Assigned to an examining attorney
    Assigned To Examiner
  7. 2 Apr 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  8. 13 Dec 2024
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  9. 23 May 2025
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 36 events
2026-08-22Notice Of Approval Of Extension Request E-Mailed
2026-08-21Case Assigned To Intent To Use Paralegal
2026-08-21Sou Extension 5 Granted
2026-06-25Sou Teas Extension Received
2026-06-25Sou Extension 5 Filed
2026-03-27Teas Change Of Owner Address Received
2026-03-27Applicant/Correspondence Changes (Non-Responsive) Entered
2026-03-27Teas Change Of Correspondence Received
2025-12-11Notice Of Approval Of Extension Request E-Mailed
2025-12-10Sou Teas Extension Received
2025-12-10Sou Extension 4 Filed
2025-12-10Sou Extension 4 Granted
2025-05-24Notice Of Approval Of Extension Request E-Mailed
2025-05-23Sou Teas Extension Received
2025-05-23Sou Extension 3 Filed
2025-05-23Sou Extension 3 Granted
2025-03-03Notice Of Approval Of Extension Request E-Mailed
2024-12-13Sou Extension 2 Granted
2024-12-12Sou Teas Extension Received
2024-12-12Sou Extension 2 Filed
2024-04-03Notice Of Approval Of Extension Request E-Mailed
2024-04-02Sou Teas Extension Received
2024-04-02Sou Extension 1 Filed
2024-04-02Sou Extension 1 Granted
2024-01-05Assigned To Examiner
2023-12-26Noa Mailed - Sou Required From Applicant
2023-11-29Teas Change Of Owner Address Received
2023-11-29Applicant/Correspondence Changes (Non-Responsive) Entered
2023-11-29Teas Change Of Correspondence Received
2023-10-31Published For Opposition
2023-10-31Official Gazette Publication Confirmation E-Mailed
2023-10-11Notification Of Notice Of Publication E-Mailed
2023-09-25Approved For Pub - Principal Register
2023-09-23Assigned To Examiner
2023-08-30New Application Office Supplied Data Entered
2023-08-04New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Class 42 Technology & SaaS

Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 22 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.